Economic evaluation of outpatients with type 2 diabetes mellitus assisted by a pharmaceutical care service

Detalhes bibliográficos
Autor(a) principal: Borges,Anna Paula de Sá
Data de Publicação: 2011
Outros Autores: Guidoni,Camilo Molino, Freitas,Osvaldo de, Pereira,Leonardo Régis Leira
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Arquivos Brasileiros de Endocrinologia & Metabologia (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27302011000900003
Resumo: OBJECTIVE: To analyze the costs related to visits and drug prescription in outpatients with type 2 diabetes mellitus assisted by a pharmaceutical care service. SUBJECTS AND METHODS: A prospective and experimental study was carried out. Seventy one patients were divided into two groups: control and pharmaceutical care. Patients in the pharmaceutical care group were followed up monthly by a single clinical pharmacist. RESULTS: The pharmaceutical care group had a statistically significant reduction in costs of metformin and emergency department visits, and increased costs with their family physicians. On the other hand, the control group had a statistically significant increase of 21.3% in the general costs of treatment and visits. CONCLUSION: The pharmaceutical care group maintained the same costs related to drugs and visits, while the control group showed a significant increase in general costs.
id SBEM-2_f9fd2fd4d628c51ec01f1ffa9a055792
oai_identifier_str oai:scielo:S0004-27302011000900003
network_acronym_str SBEM-2
network_name_str Arquivos Brasileiros de Endocrinologia & Metabologia (Online)
repository_id_str
spelling Economic evaluation of outpatients with type 2 diabetes mellitus assisted by a pharmaceutical care serviceUnified Healthcare Systemdiabetes mellitushealthcare costspharmaceutical carepharmacoeconomicsOBJECTIVE: To analyze the costs related to visits and drug prescription in outpatients with type 2 diabetes mellitus assisted by a pharmaceutical care service. SUBJECTS AND METHODS: A prospective and experimental study was carried out. Seventy one patients were divided into two groups: control and pharmaceutical care. Patients in the pharmaceutical care group were followed up monthly by a single clinical pharmacist. RESULTS: The pharmaceutical care group had a statistically significant reduction in costs of metformin and emergency department visits, and increased costs with their family physicians. On the other hand, the control group had a statistically significant increase of 21.3% in the general costs of treatment and visits. CONCLUSION: The pharmaceutical care group maintained the same costs related to drugs and visits, while the control group showed a significant increase in general costs.Sociedade Brasileira de Endocrinologia e Metabologia2011-12-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27302011000900003Arquivos Brasileiros de Endocrinologia & Metabologia v.55 n.9 2011reponame:Arquivos Brasileiros de Endocrinologia & Metabologia (Online)instname:Sociedade Brasileira de Endocrinologia e Metabologia (SBEM)instacron:SBEM10.1590/S0004-27302011000900003info:eu-repo/semantics/openAccessBorges,Anna Paula de SáGuidoni,Camilo MolinoFreitas,Osvaldo dePereira,Leonardo Régis Leiraeng2012-01-05T00:00:00Zoai:scielo:S0004-27302011000900003Revistahttps://www.aem-sbem.com/ONGhttps://old.scielo.br/oai/scielo-oai.php||abem-editoria@endocrino.org.br1677-94870004-2730opendoar:2012-01-05T00:00Arquivos Brasileiros de Endocrinologia & Metabologia (Online) - Sociedade Brasileira de Endocrinologia e Metabologia (SBEM)false
dc.title.none.fl_str_mv Economic evaluation of outpatients with type 2 diabetes mellitus assisted by a pharmaceutical care service
title Economic evaluation of outpatients with type 2 diabetes mellitus assisted by a pharmaceutical care service
spellingShingle Economic evaluation of outpatients with type 2 diabetes mellitus assisted by a pharmaceutical care service
Borges,Anna Paula de Sá
Unified Healthcare System
diabetes mellitus
healthcare costs
pharmaceutical care
pharmacoeconomics
title_short Economic evaluation of outpatients with type 2 diabetes mellitus assisted by a pharmaceutical care service
title_full Economic evaluation of outpatients with type 2 diabetes mellitus assisted by a pharmaceutical care service
title_fullStr Economic evaluation of outpatients with type 2 diabetes mellitus assisted by a pharmaceutical care service
title_full_unstemmed Economic evaluation of outpatients with type 2 diabetes mellitus assisted by a pharmaceutical care service
title_sort Economic evaluation of outpatients with type 2 diabetes mellitus assisted by a pharmaceutical care service
author Borges,Anna Paula de Sá
author_facet Borges,Anna Paula de Sá
Guidoni,Camilo Molino
Freitas,Osvaldo de
Pereira,Leonardo Régis Leira
author_role author
author2 Guidoni,Camilo Molino
Freitas,Osvaldo de
Pereira,Leonardo Régis Leira
author2_role author
author
author
dc.contributor.author.fl_str_mv Borges,Anna Paula de Sá
Guidoni,Camilo Molino
Freitas,Osvaldo de
Pereira,Leonardo Régis Leira
dc.subject.por.fl_str_mv Unified Healthcare System
diabetes mellitus
healthcare costs
pharmaceutical care
pharmacoeconomics
topic Unified Healthcare System
diabetes mellitus
healthcare costs
pharmaceutical care
pharmacoeconomics
description OBJECTIVE: To analyze the costs related to visits and drug prescription in outpatients with type 2 diabetes mellitus assisted by a pharmaceutical care service. SUBJECTS AND METHODS: A prospective and experimental study was carried out. Seventy one patients were divided into two groups: control and pharmaceutical care. Patients in the pharmaceutical care group were followed up monthly by a single clinical pharmacist. RESULTS: The pharmaceutical care group had a statistically significant reduction in costs of metformin and emergency department visits, and increased costs with their family physicians. On the other hand, the control group had a statistically significant increase of 21.3% in the general costs of treatment and visits. CONCLUSION: The pharmaceutical care group maintained the same costs related to drugs and visits, while the control group showed a significant increase in general costs.
publishDate 2011
dc.date.none.fl_str_mv 2011-12-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27302011000900003
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27302011000900003
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S0004-27302011000900003
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Endocrinologia e Metabologia
publisher.none.fl_str_mv Sociedade Brasileira de Endocrinologia e Metabologia
dc.source.none.fl_str_mv Arquivos Brasileiros de Endocrinologia & Metabologia v.55 n.9 2011
reponame:Arquivos Brasileiros de Endocrinologia & Metabologia (Online)
instname:Sociedade Brasileira de Endocrinologia e Metabologia (SBEM)
instacron:SBEM
instname_str Sociedade Brasileira de Endocrinologia e Metabologia (SBEM)
instacron_str SBEM
institution SBEM
reponame_str Arquivos Brasileiros de Endocrinologia & Metabologia (Online)
collection Arquivos Brasileiros de Endocrinologia & Metabologia (Online)
repository.name.fl_str_mv Arquivos Brasileiros de Endocrinologia & Metabologia (Online) - Sociedade Brasileira de Endocrinologia e Metabologia (SBEM)
repository.mail.fl_str_mv ||abem-editoria@endocrino.org.br
_version_ 1754734811741683712

Registros relacionados